We are live on
!
Find out more
Supernus Pharmaceuticals
SUPN
SUPN
333 hedge funds and large institutions have $2.84B invested in Supernus Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 63 funds opening new positions, 114 increasing their positions, 112 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
91% more first-time investments, than exits
New positions opened: 63 | Existing positions closed: 33
10% more call options, than puts
Call options by funds: $5.9M | Put options by funds: $5.35M
7% more funds holding
Funds holding: 310 → 333 (+23)
3% more capital invested
Capital invested by funds: $2.76B → $2.84B (+$82.1M)
2% more repeat investments, than reductions
Existing positions increased: 114 | Existing positions reduced: 112
3.28% less ownership
Funds ownership: 102.9% → 99.62% (-3.3%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
333
Holders Change
+23
Holders Change %
+7.42%
% of All Funds
4.05%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
63
Increased
114
Reduced
112
Closed
33
Calls
$5.9M
Puts
$5.35M
Net Calls
+$550K
Net Calls Change
-$11M
Top Buyers
| 1 |
Millennium Management
New York
|
+$112M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$24.5M |
| 3 |
Morgan Stanley
New York
|
+$15.8M |
| 4 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$13.2M |
| 5 |
MIM
MetLife Investment Management
Whippany,
New Jersey
|
+$13.2M |
Top Sellers
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$121M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
-$60.4M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$46.9M |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$28.5M |
| 5 |
Goldman Sachs
New York
|
-$24.4M |
